Amgen (AMGN) Tops Q2 EPS by 10c; Boosts FY16 Outlook
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $437.23 --0%
Revenue Growth %: +5.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
CAN, UNFI, SUNB, More
Revenue Growth %: +5.1%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
CAN, UNFI, SUNB, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $2.84, $0.10 better than the analyst estimate of $2.74. Revenue for the quarter came in at $5.69 billion versus the consensus estimate of $5.58 billion.
GUIDANCE:
Amgen sees FY2016 EPS of $11.10-$11.40. Amgen sees FY2016 revenue of $22.5-22.8 billion. The Street sees EPS of $11.18 and revenue of $22.57 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- BMO Capital Downgrades Amgen (AMGN) to Market Perform
- JPMorgan Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
